Clinical Trial Detail

NCT ID NCT02508077
Title FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements yes
Sponsors City of Hope Medical Center
Indications

rectum cancer

colon cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Panitumumab

Age Groups: adult

Additional content available in CKB BOOST